Group 1 - The shipping and port sector increased by 0.39% on December 25, with Chongqing Port leading the gains [1] - The Shanghai Composite Index closed at 3959.62, up 0.47%, while the Shenzhen Component Index closed at 13531.41, up 0.33% [1] - Key stocks in the shipping and port sector showed significant price increases, with Chongqing Port rising by 10.02% to a closing price of 5.82 [1] Group 2 - The shipping and port sector experienced a net outflow of 380 million yuan from main funds, while retail investors saw a net inflow of 279 million yuan [2] - The trading volume and turnover for key stocks varied, with An Tong Holdings seeing a closing price of 5.95 and a trading volume of 1.662 million shares [2] - The net inflow of funds for Chongqing Port was negative at -39.11 million yuan, indicating a shift in investor sentiment despite its price increase [3]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：601022 证券简称：宁波远洋 公告编号：2025-055 宁波远洋运输股份有限公司 关于公司董事、副总经理离任的公告 截至本公告披露日，陈加挺先生未持有公司股份，不存在应当履行而未履行 的承诺事项，并已确认与公司董事会无意见分歧，亦无任何事项须提请公司及公 司股东注意。 陈加挺先生在任职期间，恪尽职守、勤勉尽责，为公司高质量发展贡献了积 极力量。公司及公司董事会对陈加挺先生在任职期间的辛勤付出表示衷心的感谢！ 特此公告。 宁波远洋运输股份有限公司董事会 2025 年 12 月 26 日 重要内容提示： 宁波远洋运输股份有限公司（以下简称"公司"）董事会近日收到董事、 董事会战略与 ESG 委员会委员、副总经理陈加挺先生的书面辞职报告。因工作 调整，陈加挺先生申请辞去公司董事、董事会战略与 ESG 委员会委员、副总经 理职务，辞职后将不在公司及其控股子公司担任任何职务。 二、离任对公司的影响 根据《公司法》和《公司章程》等有关规定，陈加挺先生的辞职不会导致董 事会人数 ...

格隆汇12月25日丨宁波远洋(601022.SH)公布，公司董事会近日收到董事、董事会战略与ESG委员会委 员、副总经理陈加挺先生的书面辞职报告。因工作调整，陈加挺先生申请辞去公司董事、董事会战略与 ESG委员会委员、副总经理职务，辞职后将不在公司及其控股子公司担任任何职务。 ...

宁波远洋12月25日公告，公司董事会近日收到董事、副总经理陈加挺的书面辞职报告。因工作调整，陈 加挺申请辞去公司董事、副总经理等职务，辞职后将不在公司及其控股子公司担任任何职务，辞职报告 自送达董事会之日起生效。 ...

格隆汇12月25日丨宁波远洋(601022.SH)公布，公司董事会近日收到董事、董事会战略与ESG委员会委 员、副总经理陈加挺先生的书面辞职报告。因工作调整，陈加挺先生申请辞去公司董事、董事会战略与 ESG委员会委员、副总经理职务，辞职后将不在公司及其控股子公司担任任何职务。 ...

宁波远洋运输股份有限公司 2025 年第四次临时股东会会议须知 尊敬的各位股东及股东代理人： 宁波远洋运输股份有限公司（以下简称"公司"）为维护股东的合法权 益，确保股东及股东代理人在公司 2025 年第四次临时股东会期间依法行使权 利，保证股东会的正常秩序和议事效率，根据《中华人民共和国公司法》《中 华人民共和国证券法》《上市公司股东会规则》以及《公司章程》和《公司股 东会议事规则》的有关规定，特制定如下规定： 〇 宁波远洋运输股份有限公司 宁波远洋运输股份有限公司 2025 年第四次临时股东会文件目录 | 2025 | 宁波远洋运输股份有限公司 年第四次临时股东会会议须知 1 | | --- | --- | | 2025 | 宁波远洋运输股份有限公司 年第四次临时股东会会议议程 3 | | 议案一 年度日常关联交易执行情况及 | 关于公司 2025 2026 年度日常关联交易预 | | 计的议案 5 | | 宁波远洋运输股份有限公司 31 日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过互联网投票 平台的投票时间为 2024 年 12 月 31 日的 9:15-1 ...

航运界网消息，12月22日，宁波远洋运输股份有限公司（证券代码：601022，以下简称"宁波远洋"）发布公告称，董事会近日收到董事陶荣君先生，董 事、董事会秘书、副总经理蔡宇霞女士的书面辞职报告。 公告显示，因工作调整，陶荣君先生申请辞去公司董事职务，辞职后将不在公司及其控股子公司担任任何职务。蔡宇霞女士申请辞去公司董事、董事会秘 书、副总经理职务，辞职后将不在公司担任任何职务，但仍将继续担任公司全资子公司宁波远洋（新加坡）有限公司董事职务。 公告截图 航运界网消息，12月22日，宁波远洋运输股份有限公司（证券代码：601022，以下简称"宁波远洋"）发布公告称，董事会近日收到董事陶荣君先生，董 事、董事会秘书、副总经理蔡宇霞女士的书面辞职报告。 公告截图 | | | | | | 是否继续在 | | 是否存在 | | --- | --- | --- | --- | --- | --- | --- | --- | | 姓名 | 离任职务 | 离任时间 | 原定任期到 | 离任原因 | 上市公司及 | 具体职务(如 | 未履行完 | | | | | 期日 | | 其控股子公 | 适用) | 毕的公开 | | | ...

Group 1 - Rongchang Biotech plans to repurchase shares worth between 20 million and 40 million yuan, with a maximum price of 95 yuan per share, aiming to buy back approximately 21,050 to 42,110 shares, representing about 0.04% to 0.07% of total share capital [1] - Nanya New Materials intends to raise no more than 900 million yuan through a private placement for AI computing power-based high-frequency high-speed copper-clad laminate R&D and working capital [2] - Xiechuang Data has signed a strategic cooperation agreement with Ping An Financial Leasing, aiming for a cooperation scale of 2 billion yuan over three years [3] Group 2 - Chuangshi Technology's controlling shareholder is under investigation and has been placed under detention, having resigned from all positions in the company [4] - Deep Kangjia A has reported overdue shareholder loans to Yikang Technology and Chuzhou Kangxin, totaling approximately 233 million yuan and 395 million yuan respectively, due to repayment issues [5] - Ningbo Yuanyang announced the resignation of two directors due to work adjustments [6] Group 3 - China Merchants Energy has delivered the world's first methanol dual-fuel VLCC oil tanker, with 15 oil tanker orders in hand [7] - Tianyu Co., Ltd. has received a drug registration certificate for hydrochloride trazodone tablets, which are used for treating depression [8] - Haizheng Pharmaceutical has received FDA approval for clinical trials of HS387 tablets for treating advanced solid tumors [9] Group 4 - Warner Pharmaceuticals has obtained a drug registration certificate for isoproterenol hydrochloride injection, used for treating shock and complete atrioventricular block [10] - Hekang New Energy's subsidiary received a government subsidy of 1.5 million yuan, which accounts for 14.57% of the company's latest audited net profit [11] - Duku Culture is planning a change in company control, with stock suspension expected for no more than two trading days [12] Group 5 - Haisco has received acceptance for an IND application for HSK46575 tablets for prostate cancer treatment [13] - *ST Xinyan is executing a capital reserve transfer to increase share capital, resulting in a stock suspension [14] - Nanjing Public Utilities is transferring a 45% stake in a subsidiary for 23.6443 million yuan [15] Group 6 - Action Education plans to repurchase shares worth between 20 million and 25 million yuan, with a maximum price of 45 yuan per share [16] - Bai'ao Tai has received government subsidies totaling 29 million yuan [18] - Weisi Medical intends to sell assets worth 119 million yuan, expecting a profit impact of approximately 10 million yuan [19] Group 7 - Tongyu Communications plans to increase capital by 10 million yuan to introduce investment from Wuchuang Institute [20] - Dongtu Technology's subsidiary is introducing strategic investor Guofeng Investment Fund with a capital increase of 11 million yuan [21] - China General Nuclear Power Technology's shareholder is facing a judicial auction of 2.91% of the company's shares [22] Group 8 - Nanshan Aluminum plans to repurchase shares worth between 300 million and 600 million yuan, with a maximum price of 7.52 yuan per share [23] - Yipin Hong's controlling shareholder has committed to transferring 9.07% equity in Arthrosi without compensation [24] - Sanli Pharmaceutical has signed a technology transfer contract worth 200 million yuan with Hainan University [25] Group 9 - Xin Nuo Wei plans to jointly invest 450 million yuan with Zhongqi Pharmaceutical to establish a joint venture focusing on innovative metabolic drugs [26] - Li Qun Co. has been approved to issue 1 billion yuan in medium-term notes to optimize debt structure and supplement working capital [27] - Dongfang Ocean's subsidiary has received a medical device registration certificate for a procalcitonin test kit [28] Group 10 - Tibet Mining's chairman has resigned due to work adjustments [29] - Wantai Biological's subsidiary has been shortlisted for a national immunization program vaccine procurement project, with a bid price of 27.5 yuan [30] - Xingfu Blue Sea has appointed Zhang Chen as the new deputy general manager [31] Group 11 - Changyuan Donggu has elected Li Yixuan as the vice chairman of the board [32] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuang Robotics for collaboration in humanoid robot development [33] - Yongda Co. has been pre-selected for a procurement project worth approximately 350 million yuan [34] Group 12 - Fuan Pharmaceutical's subsidiary has received a drug registration certificate for hydrochloride trazodone tablets [35] - Nanjing Food reported a 71.03% year-on-year decrease in net profit for November due to rising raw material costs [36] - Changqing Technology's special polymer monomer project has commenced production [37]

2024年1至12月份，宁波远洋的营业收入构成为：运输服务占比86.34%，综合物流及代理服务占比 11.85%，其他业务占比1.81%。 截至发稿，宁波远洋市值为123亿元。 每经AI快讯，宁波远洋（SH 601022，收盘价：9.43元）12月22日晚间发布公告称，因工作调整，陶荣 君先生申请辞去公司董事职务，蔡宇霞女士申请辞去公司董事、董事会秘书、副总经理职务，但仍将继 续担任公司全资子公司宁波远洋（新加坡）有限公司董事职务。 每经头条（nbdtoutiao）——新能源重卡爆单了，11月销量同比增长178%！两班倒都供不应求，客户直 接进厂催单，这情景十年难遇 （记者 王瀚黎） ...

证券代码：601022 证券简称：宁波远洋 公告编号：2025-054 宁波远洋运输股份有限公司 关于董事、董事会秘书、副总经理离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 截至本公告披露日，陶荣君先生、蔡宇霞女士未持有公司股份，不存在应当 履行而未履行的承诺事项，并已确认与公司董事会无意见分歧，亦无任何事项须 提请公司及公司股东注意。 陶荣君先生、蔡宇霞女士在任职期间，恪尽职守、勤勉尽责，为公司高质量 发展贡献了积极力量。公司及公司董事会对两位在任职期间的辛勤付出表示衷心 的感谢！ 特此公告。 宁波远洋运输股份有限公司董事会 宁波远洋运输股份有限公司（以下简称"公司"）董事会近日收到董事 陶荣君先生，董事、董事会秘书、副总经理蔡宇霞女士的书面辞职报告。因工作 调整，陶荣君先生申请辞去公司董事职务，辞职后将不在公司及其控股子公司担 任任何职务。蔡宇霞女士申请辞去公司董事、董事会秘书、副总经理职务，辞职 后将不在公司担任任何职务，但仍将继续担任公司全资子公司宁波远洋（新加坡） 有限公司董事职务。 | ...